ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

February 29, 2028

Study Completion Date

February 28, 2029

Conditions

Glioblastoma

Interventions

DRUG

WSD0628

A non-toxic compound and inhibits the DNA damage response associated with radiation therapy. • WSD-0628 radio sensitizes Glioblastoma cells.

Trial Locations (1)

RECRUITING

Mayo Clinic in Rochester, Rochester